on a mobile?
 
vTap
    Loading...
 
 
Video
The move will give Ranbaxy access to over $1 billion in sales revenue.
5 months ago
CNN-IBN (India)
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Atorvastatin
Ranbaxy Laboratories
Pfizer
Go to Feed to see what's new!
share
keep
 
 
10515
Ranbaxy has reached a settlement with Pfizer on Lipitor litigation. Ranbaxy and Pfizer have also agreed to settle Caduet and Quinapril cases. Both the pharma majors have agreed to withdraw all ...
5 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Atorvastatin
Caduet
Pfizer
Ranbaxy Laboratories
Pharmaceutical company
Quinapril
Go to Feed to see what's new!
share
keep
 
 
On Wednesday, Pfizer Inc. said that Ranbaxy Laboratories Ltd can start selling a U.S. generic form of its cholesterol fighter, Lipitor by la...
4m 32s |
5 months ago
CNBC Video Gallery - CNBC.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Pfizer
Atorvastatin
Go to Feed to see what's new!
share
keep
 
 
14355
...abbaxy-Pfizer maybe innocent on the face of it, but does it walk a fine line with the insider trading regulations of SEBI? Expert legal personnel are of the view that there is no real spout ...
5 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Pfizer
Ranbaxy Laboratories
Insider trading
Go to Feed to see what's new!
share
keep
 
 
Arnout van Rijn, chief investment officer at Robeco Hong Kong Ltd., talks with Bloomberg's Bernard Lo about the outlook for Japanese stocks.
2 days ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Hong Kong
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
One has to analyze the situation post settlement whether Pfizer is going to go ahead or not with its counter offer and then take a call on whether one wants to jump in the fray and buy Ranbaxy at Rs 620 plus because of Lipitor
5 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Atorvastatin
Ranbaxy Laboratories
Pfizer
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums
Privacy Policy and Terms of Use